Search for: "Barr Laboratories Inc "
Results 81 - 100
of 166
Sort by Relevance
|
Sort by Date
16 Jun 2010, 3:02 pm
Paddock Laboratories Inc. [read post]
10 Jun 2010, 3:58 am
Paddock Laboratories, Inc. [read post]
7 Jun 2010, 9:36 am
PSC Computer Prods., Inc. v. [read post]
3 Jun 2010, 9:36 pm
By James DeGiulio -- Celgene, Barr Resolve Patent Dispute over Generic Thalomid Celgene Corp. and Barr Laboratories Inc. have resolved their patent dispute over the multiple myeloma cancer drug Thalomid, with Celgene agreeing to drop its patent infringement claims and Barr dropping its invalidity and antitrust claims. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
13 May 2010, 4:58 pm
Barr Laboratories, Inc. [read post]
10 May 2010, 9:34 pm
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
7 May 2010, 1:07 pm
Barr Laboratories, Inc. [read post]
5 May 2010, 10:14 pm
Barr Labs., Inc., 437 F.3d 1181 (Fed. [read post]
7 Apr 2010, 3:44 pm
Click Here EPA Settles with Drug and Laboratory Disposal on Hazardous Waste Violations. [read post]
3 Apr 2010, 6:19 pm
Barr Laboratories Inc (PDF)., 251 F.3d 955, 963, 58 USPQ2d 1865, 1874 (Fed. [read post]
24 Mar 2010, 4:45 am
Impax Laboratories, Inc. [read post]
18 Mar 2010, 2:30 am
Paddock Laboratories, Inc. [read post]
4 Mar 2010, 12:38 am
Ocella, which is a generic version of Yasmin, is distributed by Barr Laboratories, Inc. [read post]
3 Mar 2010, 12:49 pm
Bayer, makers of the popular, but problematic birth control drug Yaz and Yasmin wrote that there were, about 1,100 lawsuits pending in the United States served on Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products Yasmin®, yaz® and / or Ocella, a generic version of Yasmin® distributed by Barr Laboratories, Inc. in the u.s. market. [read post]
3 Mar 2010, 7:55 am
" (Posted by Tom Lamb at DrugInjuryWatch.com) The Bayer Annual Report for 2009, at page 243, provides some updated information about the number of YAZ, Yasmin, and Ocella lawsuits that have been filed thus far: As of February 15, 2010, there were about 1,100 lawsuits pending in the United States served upon Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products Yasmin®, YAZ® and / or… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
18 Feb 2010, 10:34 am
Most notably there’s Mylan Laboratories, Inc. v. [read post]
